Literature DB >> 26958147

Analysis of Spinal Cord Infarction Associated with Aortic Stent Graft Placement Using Nationwide Inpatient Sample (2002-2011).

Adnan I Qureshi1, Morad Chughtai1, Ahmed A Malik1.   

Abstract

PURPOSE: We performed this study to identify the rate and determinants of and associated outcomes with spinal cord infarction among patients treated with aortic stent graft placement at a national level.
METHODS: We analyzed the data files from Nationwide Inpatient Sample (NIS) from 2002 to 2011. We performed multivariate logistic regression analysis to assess the rates of moderate to severe disability or death in patients with and without spinal cord infarction after adjusting for age, gender, and comorbidities that were significant in univariate analysis. We also determined change in annual rates of spinal cord infarction associated with aortic stent graft placement from 2002 through 2011.
RESULTS: Spinal cord infarction occurred in 761 (0.2%) of 305,788 patients who underwent aortic stent graft placement. There was an increase in the annual rate of spinal cord infarction among patients who underwent aortic stent graft placement from 2002 (0.03%) to 2011 (0.4%) (p <0.001). The patients who developed spinal cord infarction had significantly higher odds of in hospital mortality ([odd ratio] OR: 3.0; 95% confidence interval [CI]: 2.4-3.8) after adjusting for age, gender, race/ethnicity, aortic aneurysms, thoracic graft, hypertension, ischemic strokes or transient ischemic attacks, coagulopathy, congestive heart failure, deficiency or chronic blood loss anemia, atrial fibrillation, renal failure, elective admission, and teaching hospital status. Among those who were discharged alive, patients who developed spinal cord infarction had significantly higher odds of moderate to severe disability (OR: 2.8; 95% CI: 2.5-3.2).
CONCLUSIONS: The occurrence of spinal cord infarction in patients undergoing aortic stent graft placement appears to be increasing. Spinal cord infarction is associated with prominently higher rates of death and moderate to severe disability.

Entities:  

Keywords:  Aortic aneurysm; Aortic graft; Aortic stent; Spinal cord infarction

Year:  2016        PMID: 26958147      PMCID: PMC4762405     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  30 in total

1.  A case of paraplegia following endovascular stent repair of descending thoracic aortic aneurysm.

Authors:  Min Young Lee; Myung-Goo Lee; Kyung-Soon Hong; Chang Yul Lee; Kyu Tae Park; Chan Woo Lee; Myeong Shin Ryu; Young Muk Kim; Dae Hyun Hwang
Journal:  Korean Circ J       Date:  2011-03-31       Impact factor: 3.243

2.  Open and endovascular repair of type B aortic dissection in the Nationwide Inpatient Sample.

Authors:  Teviah Sachs; Frank Pomposelli; Robert Hagberg; Allen Hamdan; Mark Wyers; Kristina Giles; Marc Schermerhorn
Journal:  J Vasc Surg       Date:  2010-10       Impact factor: 4.268

3.  Risk factors, outcomes, and clinical manifestations of spinal cord ischemia following thoracic endovascular aortic repair.

Authors:  Brant W Ullery; Albert T Cheung; Ronald M Fairman; Benjamin M Jackson; Edward Y Woo; Joseph Bavaria; Alberto Pochettino; Grace J Wang
Journal:  J Vasc Surg       Date:  2011-05-14       Impact factor: 4.268

4.  Safety of elective management of synchronous aortic disease with simultaneous thoracic and aortic stent graft placement.

Authors:  Salvatore T Scali; Robert J Feezor; Catherine K Chang; David H Stone; Philip P Goodney; Peter R Nelson; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2012-06-27       Impact factor: 4.268

5.  Risk of spinal cord ischemia after endograft repair of thoracic aortic aneurysms.

Authors:  E C Gravereaux; P L Faries; J A Burks; V Latessa; D Spielvogel; L H Hollier; M L Marin
Journal:  J Vasc Surg       Date:  2001-12       Impact factor: 4.268

6.  Impact of International Subarachnoid Aneurysm Trial results on treatment of ruptured intracranial aneurysms in the United States. Clinical article.

Authors:  Adnan I Qureshi; Gabriela Vazquez; Nauman Tariq; M Fareed K Suri; Kamakshi Lakshminarayan; Giuseppe Lanzino
Journal:  J Neurosurg       Date:  2010-07-23       Impact factor: 5.115

7.  Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis.

Authors:  Michel S Makaroun; Ellen D Dillavou; Stephen T Kee; Gregorio Sicard; Elliot Chaikof; Joseph Bavaria; David Williams; Richard P Cambria; R Scott Mitchell
Journal:  J Vasc Surg       Date:  2005-01       Impact factor: 4.268

8.  Spinal cord ischemia following endovascular repair of an infrarenal aortic aneurysm.

Authors:  Nicholas D Garcia; Hassan Tehrani; Mark Morasch; William Pearce; Jon Matsumura
Journal:  Ann Vasc Surg       Date:  2002-07-24       Impact factor: 1.466

9.  Endovascular treatment of thoracic aortic diseases: combined experience from the EUROSTAR and United Kingdom Thoracic Endograft registries.

Authors:  Lina J Leurs; Rachel Bell; Yvan Degrieck; Steve Thomas; Roel Hobo; Jan Lundbom
Journal:  J Vasc Surg       Date:  2004-10       Impact factor: 4.268

10.  Hypogastric and subclavian artery patency affects onset and recovery of spinal cord ischemia associated with aortic endografting.

Authors:  Matthew J Eagleton; Samir Shah; Dan Petkosevek; Tara M Mastracci; Roy K Greenberg
Journal:  J Vasc Surg       Date:  2013-11-01       Impact factor: 4.268

View more
  2 in total

1.  Rates of Spinal Cord Infarction After Repair of Aortic Aneurysm or Dissection.

Authors:  Gino Gialdini; Neal S Parikh; Abhinaba Chatterjee; Michael P Lerario; Hooman Kamel; Darren B Schneider; Babak B Navi; Santosh B Murthy; Costantino Iadecola; Alexander E Merkler
Journal:  Stroke       Date:  2017-06-27       Impact factor: 7.914

2.  Traumatic Injury of Major Cerebral Venous Sinuses Associated with Traumatic Brain Injury or Head and Neck Trauma: Analysis of National Trauma Data Bank.

Authors:  Adnan I Qureshi; Sindhu Sahito; Jahanzeb Liaqat; Premkumar Nattanmai Chandrasekaran; Farhan Siddiq
Journal:  J Vasc Interv Neurol       Date:  2020-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.